Position history for BlackRock, Inc.'s holdings in TERNS PHARMACEUTICALS INC
BlackRock, Inc. holds 8.2M shares of TERN (TERNS PHARMACEUTICALS INC), worth $331M as of 2025-Q4. The position was increased (++47.6% shares). TERN represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$331M
Current Shares
8.2M
Total Value Change
+$299.2M
Total Shares Change
+2.5M
Other major holders of TERN: MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, Avoro Capital Advisors LLC, JANUS HENDERSON GROUP PLC
Increased |
| 8.2M |
+47.6% |
| $331M |
| 0.0% |
| $40.59 |
42 |
| 2025-Q3 | Increased | 5.6M | +1.5% | $41.7M | 0.0% | $7.79 | 29 |
| 2025-Q2 | Decreased | 5.5M | -4.1% | $20.4M | 0.0% | $3.83 | 0 |
| 2025-Q1 | Decreased | 5.7M | -0.6% | $15.8M | 0.0% | $2.92 | 0 |
| 2024-Q4 | New | 5.7M | - | $31.8M | 0.0% | $5.53 | 40 |